Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Brainomix Ltd.

Brainomix, a medical diagnostics software company, was founded in 2010 as a spin-out from the University of Oxford and is dedicated to improving outcomes for patients with neurological and cerebrovascular disorders. Brainomix is currently focusing on acute stroke. By developing and equipping physicians with world-class, artificial intelligence-based medical imaging software, Brainomix aims to help them in making life-saving treatment decisions by supporting the selection of the right treatment for the right stroke patient. *

 

Period Start 2010-01-01 splitoff
  Predecessor University of Oxford
Products Industry e-CTA software
  Industry 2 e-ASPECTS software (automating Alberta Stroke Program Early CT Score (ASPECTS) method)
Person Person Papadakis, Michalis (Brainomix 201804 CEO)
     
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  Street 263 Banbury Road
Suffolk House, Suite 11–14
  City OX2 7HN Oxford, Oxfordshire
  Tel +44-1865-582730
    Address record changed: 2018-04-03
     
Basic data Employees n. a.
     
    * Document for �About Section�: Brainomix Ltd.. (4/3/18). "Press Release: Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes with AI". Oxford.
     
   
Record changed: 2018-09-12

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Brainomix Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top